Multiple Sclerosis Treatments.
There are various MS treatments available today that have been shown to decrease the frequency of relapses and to delay disease progression. There are several ways that these MS treatments can be taken. Some MS treatments use an injection—either subcutaneous (under the skin) or intramuscular (into the muscle)—while others are given intravenously (via an infusion) or orally (by mouth).
- Beta interferons are injectable medications used for relapsing-remitting MS treatment. Certain beta interferon products also may be used for a first clinical episode with MRI findings consistent with MS. Depending on the medication, injections for beta interferons can be either subcutaneous or intramuscular and dosing can vary from every other day to once a week.
- Glatiramer acetate is given by subcutaneous injection every day for relapsing-remitting MS treatment. It is also used for patients who have experienced a first clinical episode and have MRI findings consistent with MS.
- Fingolimod is a once-daily oral capsule indicated for the relapsing forms of MS treatment to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability
- Dimethyl fumarate is an oral capsule taken twice a day that is used for relapsing forms of MS treatment.
- Mitoxantrone is a chemotherapeutic agent for the Multiple Sclerosis treatments (worsening relapsing-remitting MS, progressive-relapsing MS or secondary-progressive MS), and is used to reduce neurologic disability and/or the frequency of clinical exacerbations. It is administered intravenously by an infusion once every three months
- Natalizumab is an intravenous multiple sclerosis treatment reserved for patients with rapidly progressing MS or with high disease activity despite the use of an alternate MS therapy. It is administered once every four weeks.